Love Hemp Group PLC - Update Regarding Trading Suspension
RNS Number : 7441K
Love Hemp Group PLC
09 May 2022

9 May 2022


Love Hemp Group PLC

("Love Hemp", the "Group", or the "Company")


Update Regarding Trading Suspension

Love Hemp Group PLC (AQSE: LIFE) (OTCQB: WRHLF), the brand-led consumer goods company focussed on CBD health and wellness solutions, wishes to provide an update on the temporary suspension of the trading in shares of Love Hemp.

As previously announced, the reason for the suspension is that Peterhouse Capital Limited ("Peterhouse") has resigned as the AQSE Corporate Advisor and the Company needs to appoint a new AQSE Corporate Advisor in order that trading can recommence on the AQSE Exchange. Love Hemp is in discussions with a new AQSE Corporate Advisor and expects to update the market with an appointment soon.


Peterhouse resigned following the update by the Company that an investor in the February 2022 placing had failed to complete their investment of £1.2 million.


The Board of Directors has commenced an ongoing review of the events that led to the suspension in trading and following the conclusion of that review will put in place any additional controls that are recommended by such review in order to prevent the potential for a similar issue occurring in the future. 


In addition, the Board is undertaking a Board structure review being conducted by its independent non-executive Director. Two new Board positions have been identified as being required and a search will commence immediately for a Chief Financial Officer and another independent non-executive Director. Any other Board changes will be communicated once the review is complete. 


As previously announced on 4 February 2022, Love Hemp is also part way through an operational review and strategic review with the objective to accelerate profitable sales growth, as well as imposing additional rigour and governance on its operations and financial performance. The Board is committed to ensuring that this review is completed as quickly as possible and will be communicated to shareholders.


Andrew Male, Executive Chairman and Director commented; "The board are committed to protecting Love Hemp's "best in class" brand reputation and the current Board, strategic and operational review will ensure this is achieved. The Board believes Love Hemp has significant growth opportunities and our review is designed to support this growth and enhance long term shareholder value."




For further information please visit: or contact:


Love Hemp Group

Andrew Male
Chairman & Director


+44 (0) 7926 397 675


Financial PR

Tim Blythe/Madeleine Gordon-Foxwell



+44 (0) 207 138 3204


About Love Hemp Group

Love Hemp Group is a brand-led consumer goods company focussed on health and wellness solutions for consumer use cases including sleep, pain, anxiety, stress and recovery. The Company is a pioneer in the UK-based premium high-quality CBD market, with over 40 products including oils, edibles, sprays, cosmetics and topicals. The Company's range of products are sold online across 70 websites and in over 2,000 stores including some of the biggest retailers in the UK, such as Holland & Barrett, Boots and Ocado. Listed on the Aquis Stock Exchange (AQSE: LIFE) the Company recently changed its name to Love Hemp Group plc, from World High Life, to better reflect its focus on supporting the "best in class" CBD brand as it embarks on a wider expansion of its core business and offering.


Market Abuse Regulation (MAR) Disclosure

The information contained within this announcement is deemed by the Company to constitute inside information. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.